Virtu Financial LLC purchased a new position in FTAC Zeus Acquisition Corp. (NASDAQ:ZING – Get Rating) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 11,155 shares of the company's stock, valued at approximately $110,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Sage Mountain Advisors LLC purchased a new stake in FTAC Zeus Acquisition in the 2nd quarter valued at approximately $43,000. Basso Capital Management L.P. acquired a new stake in FTAC Zeus Acquisition in the 1st quarter valued at $121,000. Wealthspring Capital LLC acquired a new stake in FTAC Zeus Acquisition in the 2nd quarter valued at $129,000. Kohlberg Kravis Roberts & Co. L.P. acquired a new stake in shares of FTAC Zeus Acquisition during the first quarter valued at about $154,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of FTAC Zeus Acquisition during the first quarter valued at about $156,000.

FTAC Zeus Acquisition Stock Performance

Shares of FTAC Zeus Acquisition stock opened at $10.04 on Friday. FTAC Zeus Acquisition Corp. has a 1-year low of $9.72 and a 1-year high of $10.36. The business has a 50-day moving average of $10.03 and a 200-day moving average of $9.94.

About FTAC Zeus Acquisition

FTAC Zeus Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as FTAC Hera Acquisition Corp. and changed its name to FTAC Zeus Acquisition Corp.

Featured Stories

• Get a free copy of the StockNews.com research report on FTAC Zeus Acquisition (ZING)
• MarketBeat: Week in Review 12/05 – 12/09
• There Is Fundamental Value In Broadcom, And It Yields 3.35%
• Costco vs Amazon: an end of the year showdown
• Discount Retailers Could Make Good Bargain Stocks
• Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

Receive News & Ratings for FTAC Zeus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FTAC Zeus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.